272 related articles for article (PubMed ID: 22341225)
1. 3D/4D functional imaging of tumor-associated proteolysis: impact of microenvironment.
Moin K; Sameni M; Victor BC; Rothberg JM; Mattingly RR; Sloane BF
Methods Enzymol; 2012; 506():175-94. PubMed ID: 22341225
[TBL] [Abstract][Full Text] [Related]
2. Live-Cell Imaging of Protease Activity: Assays to Screen Therapeutic Approaches.
Chalasani A; Ji K; Sameni M; Mazumder SH; Xu Y; Moin K; Sloane BF
Methods Mol Biol; 2017; 1574():215-225. PubMed ID: 28315254
[TBL] [Abstract][Full Text] [Related]
3. Spatio-temporal modeling and live-cell imaging of proteolysis in the 4D microenvironment of breast cancer.
Ji K; Sameni M; Osuala K; Moin K; Mattingly RR; Sloane BF
Cancer Metastasis Rev; 2019 Sep; 38(3):445-454. PubMed ID: 31605250
[TBL] [Abstract][Full Text] [Related]
4. Live-cell imaging of tumor proteolysis: impact of cellular and non-cellular microenvironment.
Rothberg JM; Sameni M; Moin K; Sloane BF
Biochim Biophys Acta; 2012 Jan; 1824(1):123-32. PubMed ID: 21854877
[TBL] [Abstract][Full Text] [Related]
5. Imaging and quantifying the dynamics of tumor-associated proteolysis.
Sameni M; Cavallo-Medved D; Dosescu J; Jedeszko C; Moin K; Mullins SR; Olive MB; Rudy D; Sloane BF
Clin Exp Metastasis; 2009; 26(4):299-309. PubMed ID: 19082919
[TBL] [Abstract][Full Text] [Related]
6. MAME models for 4D live-cell imaging of tumor: microenvironment interactions that impact malignant progression.
Sameni M; Anbalagan A; Olive MB; Moin K; Mattingly RR; Sloane BF
J Vis Exp; 2012 Feb; (60):. PubMed ID: 22371028
[TBL] [Abstract][Full Text] [Related]
7. High-throughput fluorescence imaging approaches for drug discovery using in vitro and in vivo three-dimensional models.
Martinez NJ; Titus SA; Wagner AK; Simeonov A
Expert Opin Drug Discov; 2015 Dec; 10(12):1347-61. PubMed ID: 26394277
[TBL] [Abstract][Full Text] [Related]
8. Functional imaging of tumor proteolysis.
Sloane BF; Sameni M; Podgorski I; Cavallo-Medved D; Moin K
Annu Rev Pharmacol Toxicol; 2006; 46():301-15. PubMed ID: 16402907
[TBL] [Abstract][Full Text] [Related]
9. Cancer drug discovery: recent innovative approaches to tumor modeling.
Lovitt CJ; Shelper TB; Avery VM
Expert Opin Drug Discov; 2016 Sep; 11(9):885-94. PubMed ID: 27454169
[TBL] [Abstract][Full Text] [Related]
10. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy.
Amoedo ND; Obre E; Rossignol R
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330
[TBL] [Abstract][Full Text] [Related]
11. Microfluidics Enabled Bottom-Up Engineering of 3D Vascularized Tumor for Drug Discovery.
Agarwal P; Wang H; Sun M; Xu J; Zhao S; Liu Z; Gooch KJ; Zhao Y; Lu X; He X
ACS Nano; 2017 Jul; 11(7):6691-6702. PubMed ID: 28614653
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiologically relevant in vitro tumor models for drug screening.
Das V; Bruzzese F; Konečný P; Iannelli F; Budillon A; Hajdúch M
Drug Discov Today; 2015 Jul; 20(7):848-55. PubMed ID: 25908576
[TBL] [Abstract][Full Text] [Related]
13. Pathomimetic cancer avatars for live-cell imaging of protease activity.
Ji K; Heyza J; Cavallo-Medved D; Sloane BF
Biochimie; 2016 Mar; 122():68-76. PubMed ID: 26375517
[TBL] [Abstract][Full Text] [Related]
14. Live-cell super-resolution imaging goes multicolor.
Klein T; van de Linde S; Sauer M
Chembiochem; 2012 Sep; 13(13):1861-3. PubMed ID: 22807353
[TBL] [Abstract][Full Text] [Related]
15. Microfluidic 3D models of cancer.
Sung KE; Beebe DJ
Adv Drug Deliv Rev; 2014 Dec; 79-80():68-78. PubMed ID: 25017040
[TBL] [Abstract][Full Text] [Related]
16. Single-Cell Live Imaging.
Hiratsuka T; Komatsu N
Methods Mol Biol; 2019; 1979():409-421. PubMed ID: 31028651
[TBL] [Abstract][Full Text] [Related]
17. High-throughput screening in multicellular spheroids for target discovery in the tumor microenvironment.
Calpe B; Kovacs WJ
Expert Opin Drug Discov; 2020 Aug; 15(8):955-967. PubMed ID: 32364413
[TBL] [Abstract][Full Text] [Related]
18. Functional imaging of proteases: recent advances in the design and application of substrate-based and activity-based probes.
Edgington LE; Verdoes M; Bogyo M
Curr Opin Chem Biol; 2011 Dec; 15(6):798-805. PubMed ID: 22098719
[TBL] [Abstract][Full Text] [Related]
19. Accelerating precision anti-cancer therapy by time-lapse and label-free 3D tumor slice culture platform.
Xing F; Liu YC; Huang S; Lyu X; Su SM; Chan UI; Wu PC; Yan Y; Ai N; Li J; Zhao M; Rajendran BK; Liu J; Shao F; Sun H; Choi TK; Zhu W; Luo G; Liu S; Xu L; Chan KL; Zhao Q; Miao K; Luo KQ; Ge W; Xu X; Wang G; Liu TM; Deng CX
Theranostics; 2021; 11(19):9415-9430. PubMed ID: 34646378
[TBL] [Abstract][Full Text] [Related]
20. Contributions of 3D Cell Cultures for Cancer Research.
Ravi M; Ramesh A; Pattabhi A
J Cell Physiol; 2017 Oct; 232(10):2679-2697. PubMed ID: 27791270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
